Aims: The discontinuation of oral anticoagulants (OACs) remains as a significant concern in
the management of atrial fibrillation (AF). The discontinuation rate may vary depending on …

Introduction Adherence to oral anticoagulation (OAC) treatment, vitamin K antagonists or
new oral anticoagulants, is an essential element for effectiveness. Information on adherence …

Aims Studies on adherence and persistence with non-vitamin K oral anticoagulant (NOAC)
treatment have relied on data from the early years of NOAC availability. We aimed to study …

Background Suboptimal adherence to direct oral anticoagulants (DOACs) among Atrial
Fibrillation (AF) patients remains currently a major concern due to the increased risk of …

Background Patient clinical factors and social determinants of health (SDOH) are associated
with an increased risk of stroke for patients with atrial fibrillation (AF); however, the …

Objective The aim of this study was to examine the association between medication
adherence and illness perceptions, and to explore the factors associated with poor …

Background: The current status and outcomes of direct oral anticoagulant (DOAC) use have
not been widely evaluated in unselected patients with atrial fibrillation (AF) in the real world …

BACKGROUND: Medication adherence and persistence is fundamental for drug
effectiveness, which is also true for the prevention of strokes in patients with atrial fibrillation …

Background Oral anticoagulation (OAC) is paramount to effective thromboprophylaxis; yet
adherence to OAC remains largely suboptimal in patients with atrial fibrillation (AF). Purpose …

Abstract Background and Objectives Atrial fibrillation (AF) and the associated risk of stroke
are emerging epidemics throughout the world. Suboptimal use of oral anticoagulants for …